BIO5 member John Elfar and colleagues at the University of Arizona found that erythropoietin, a drug used for anemia, may speed healing in nerve crush injuries by boosting repair cells and clearing debris, offering a potential new treatment path

BIO5 member Emmanuel Katsanis of the University of Arizona Comprehensive Cancer Center has transformed pediatric cancer care in Arizona, leading advances in bone marrow transplantation and immunotherapy that have raised survival rates and expanded access to lifesaving treatments.

BIO5 member Zelieann Craig is leading a $2.8M NIH-funded study exploring how phthalate exposure impacts fertility and metabolism, with the goal of uncovering ways to block or reverse these effects.